Seroxat yellow cards rose by 61% after Panorama - yeah made their own!
http://groups.yahoo.com/group/uksurvivors/message/46433
extract - from Seroxat NewsletterBBC Panorama is planning to broadcast a follow up to the `Secrets of Seroxat' documentary in May. Many of you who contacted the programme will have been asked by the producer to fill in a special version of the Yellow Card designed for Panorama by MIND. The Yellow Card system is used by GPs to report drug safety issues to the Medicine's Control Agency. If your GP has not already filled in a Yellow Card about Seroxat, please ask them to do so.see full document here
http://www.seroxatusergroup.org.UK/Documents/newsletter2.doc
Seroxat is also known as Paxil and Aropax. Blog exposes Bob Fiddaman Human rights abuser who won two SCIENTOLOGY CCHR (human rights!) awards.
blogs created to prevent or detect a crime http://www.opsi.gov.uk/acts/acts1997/ukpga_19970040_en_1
This blog is brougt to you consistent with subsection 3 of the Protection from Harassment Act - i.e. blogs created to prevent or detect a crime http://www.opsi.gov.uk/acts/acts1997/ukpga_19970040_en_1
Thursday, 14 October 2010
Seroxat yellow cards rose by 61% after Panorama - yeah made their own!
media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions
Br J Clin Pharmacol. 2006 February; 61(2): 224–228.
Published online 2005 October 27. doi: 10.1111/j.1365-2125.2005.02527.x. PMCID: PMC1884992
Copyright © 2005 Blackwell Publishing Ltd
Did intense adverse media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions? Analysis of routine databases, 2001–2004
Richard M Martin, Margaret May, and David Gunnell
Department of Social Medicine, University of Bristol, Bristol, UK
Correspondence Richard Martin, Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol BS8 2PR, UK. Tel: + 117 928 7321 Fax: + 117 928 7236 E-mail: Email: richard.martin@bristol.ac.uk
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884992/
Figure 2
Suspected adverse drug reactions to paroxetine (yellow-card reports) per 100 000 paroxetine prescriptions by year and month between 2001 and 2004. Arrows indicate dates of Panorama programmes (solid arrows) or regulatory communications (dashed arrows)
Analysis of yellow-card data suggests that adverse publicity, particularly the three Panorama programmes, was associated with marked, short-term peaks in reporting (Figure 2). The mean rate of yellow-card reporting (per 100 000 prescriptions) in the month before each regulatory announcement was 7.6 vs. 8.0 in the month after. In contrast, the mean rate of yellow-card reporting in the month before each media publicity episode was 8.3 vs. 13.4 in the month after. An identical pattern of peaks and troughs in yellow-card reporting of suspected adverse drug reactions to paroxetine was observed when the temporal trend in number of reports was plotted (data not shown).
From:Br J Clin Pharmacol. 2006 February; 61(2): 224–228.
Published online 2005 October 27. doi: 10.1111/j.1365-2125.2005.02527.x.Copyright © 2005 Blackwell Publishing Ltd
Published online 2005 October 27. doi: 10.1111/j.1365-2125.2005.02527.x. PMCID: PMC1884992
Copyright © 2005 Blackwell Publishing Ltd
Did intense adverse media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions? Analysis of routine databases, 2001–2004
Richard M Martin, Margaret May, and David Gunnell
Department of Social Medicine, University of Bristol, Bristol, UK
Correspondence Richard Martin, Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol BS8 2PR, UK. Tel: + 117 928 7321 Fax: + 117 928 7236 E-mail: Email: richard.martin@bristol.ac.uk
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884992/
Figure 2
Suspected adverse drug reactions to paroxetine (yellow-card reports) per 100 000 paroxetine prescriptions by year and month between 2001 and 2004. Arrows indicate dates of Panorama programmes (solid arrows) or regulatory communications (dashed arrows)
Analysis of yellow-card data suggests that adverse publicity, particularly the three Panorama programmes, was associated with marked, short-term peaks in reporting (Figure 2). The mean rate of yellow-card reporting (per 100 000 prescriptions) in the month before each regulatory announcement was 7.6 vs. 8.0 in the month after. In contrast, the mean rate of yellow-card reporting in the month before each media publicity episode was 8.3 vs. 13.4 in the month after. An identical pattern of peaks and troughs in yellow-card reporting of suspected adverse drug reactions to paroxetine was observed when the temporal trend in number of reports was plotted (data not shown).
From:Br J Clin Pharmacol. 2006 February; 61(2): 224–228.
Published online 2005 October 27. doi: 10.1111/j.1365-2125.2005.02527.x.Copyright © 2005 Blackwell Publishing Ltd
Seroxat consumption massive decline - how did the manage to withdraw?
Wednesday, 13 October 2010
Solicitors Regulation Authority - Fraud and Confidential Intelligence Bureau
http://www.sra.org.uk/solicitors/scams/fraud-dishonesty.page
Our Fraud and Confidential Intelligence Bureau is dedicated to gathering information and intelligence, operating in accordance with the National Intelligence Model.
If you know, or suspect, that another regulated person, or their employee, is involved in dishonest or serious misconduct, contact our Red Alert line on 0845 850 0999 or 01926 439673 or email redalert@sra.org.uk. Red Alert is available to all members of the profession and their staff who want to report concerns.
Any report you make is treated with strict confidentiality.
Our Fraud and Confidential Intelligence Bureau is dedicated to gathering information and intelligence, operating in accordance with the National Intelligence Model.
If you know, or suspect, that another regulated person, or their employee, is involved in dishonest or serious misconduct, contact our Red Alert line on 0845 850 0999 or 01926 439673 or email redalert@sra.org.uk. Red Alert is available to all members of the profession and their staff who want to report concerns.
Any report you make is treated with strict confidentiality.
Seroxat group aims are © Copyright Hugh James Solicitors 2002. - thanks to the Wayback machine crooked lawyer Mark Harvey can run but cannot hide
Seroxat group aims are © Copyright Hugh James Solicitors 2002. - thanks to the Wayback machine crooked lawyer Mark Harvey can run but cannot hide
http://web.archive.org/web/20021121121915/http://www.hughjames.com/dsp_callback.cfm
http://web.archive.org/web/20021121121915/http://www.hughjames.com/dsp_callback.cfm
Sarah Venn barrister abandoned seroxat user group Nov 2003 - WHY?
Sarah Venn barrister wanted Seroxat personal experiences considered but NOT the other brands - what a cow
The Users Group remains concerned, however, that the MCA has still not agreed to consider the personal experiences of Seroxat users in the review of the drug. Sarah Venn said: “We have offered to provide the MCA with all the information we have gathered about adverse reactions, dependence and withdrawal reactions, but they have not decided how or even if they will include patients’ experiences in the review. That is extremely worrying and we will continue to press them on this important point.”
Good Relations - Noreen Bray - Goodrelations - Seroxat User Group mouthpiece
[DOC] PRESS RELEASE
File Format: Microsoft Word - View as HTML
www.seroxatusergroup.org.uk. PRESS RELEASE. jw0328 ssri review. 28 March 2003 ... John Wilkinson / Noreen Bray. Good Relations. T 029 2034 4888.
www.seroxatusergroup.org.uk/.../jw0328%20ssri%20review%20panel%20dissolved.doc
File Format: Microsoft Word - View as HTML
www.seroxatusergroup.org.uk. PRESS RELEASE. jw0328 ssri review. 28 March 2003 ... John Wilkinson / Noreen Bray. Good Relations. T 029 2034 4888.
www.seroxatusergroup.org.uk/.../jw0328%20ssri%20review%20panel%20dissolved.doc
Shelley Jofre & Panorama misled UK public over SSRI Seroxat
Shelley Jofre & Panorama misled UK public over SSRI Seroxat
Seroxat - How the BBC misled UK viewers in attempt to bolster UK Class Action
div>
Powered by Podbean.com
Podcast transcript -
Jofre says although problems with whole class of antidepressants we (bbc) decided to concentrate on Seroxat
http://coventryuniversity.podbean.com/2007/11/01/one-woman-a-multinational-and-a-victory-shelley-jofre-panorama/
2.30 in Jofre says - " read a little bit in news paper about patients complaints" year 2000 about " Seroxat difficult to withdraw from" .. Jofre found it intriguing Jofre had only just started working on Panorama at that stage3.30 in " Jofre calls SSRI's "SELECTIVE Serotonin Reuptake Inhibitors"4.14 Jofre knew little of how the pharmcutical industry worked4 .30 in Ed says - lets look at antidepressant story4 45 Jofre says although problems with whole class of antidepressants we (bbc) decided to concentrate on SeroxatWhy we narrowed down on Seroxat1 because it was made by GSK2 all the drugs in class cause suicidal thinking on dose change3 Seroxat had a unique problem of withdrawal BECAUSE IT WAS LONGER ACTING ... we decided to focus research into this drug 6.00 in - 40 min Panorama film took Shelley Jofre 8 months to make6.10 in - It's not something you do lightly WE WERE TAKING ON the worlds second largest drug company7.30 We were talking to the lawyer the whole way through production9.30 in - Jofre says "we took a punt" on Dr David Healy
Seroxat - How the BBC misled UK viewers in attempt to bolster UK Class Action
div>
Powered by Podbean.com
Podcast transcript -
Jofre says although problems with whole class of antidepressants we (bbc) decided to concentrate on Seroxat
http://coventryuniversity.podbean.com/2007/11/01/one-woman-a-multinational-and-a-victory-shelley-jofre-panorama/
2.30 in Jofre says - " read a little bit in news paper about patients complaints" year 2000 about " Seroxat difficult to withdraw from" .. Jofre found it intriguing Jofre had only just started working on Panorama at that stage3.30 in " Jofre calls SSRI's "SELECTIVE Serotonin Reuptake Inhibitors"4.14 Jofre knew little of how the pharmcutical industry worked4 .30 in Ed says - lets look at antidepressant story4 45 Jofre says although problems with whole class of antidepressants we (bbc) decided to concentrate on SeroxatWhy we narrowed down on Seroxat1 because it was made by GSK2 all the drugs in class cause suicidal thinking on dose change3 Seroxat had a unique problem of withdrawal BECAUSE IT WAS LONGER ACTING ... we decided to focus research into this drug 6.00 in - 40 min Panorama film took Shelley Jofre 8 months to make6.10 in - It's not something you do lightly WE WERE TAKING ON the worlds second largest drug company7.30 We were talking to the lawyer the whole way through production9.30 in - Jofre says "we took a punt" on Dr David Healy
Seroxat litigation panic as Mark Harvey sends in Goodrelations to spy on Bob Fiddaman blog
Visitor Information: ip-87-86-28-98.easynet.co.uk (TRANS EUROPEAN TECHNOLOGY - GOOD RELATIONS LTD) [Label Visitor]
Location: -, -, UNITED KINGDOM (EASYNET.CO.UK)
Last Visit Time: October 13, 2010 9:22:51 AM Length of this Visit: 0 hours and 12 minutes
Page Viewed This Visit: 5 Returning Visits: 0
Entry Page: http://bobfiddaman.blogspot.com/2010/10/seroxat-truth-suit-comprises-only-314.html
Exit Page: http://bobfiddaman.blogspot.com/2010/10/seroxat-truth-suit-comprises-only-314.html
Referrer: No referrer
Location: -, -, UNITED KINGDOM (EASYNET.CO.UK)
Last Visit Time: October 13, 2010 9:22:51 AM Length of this Visit: 0 hours and 12 minutes
Page Viewed This Visit: 5 Returning Visits: 0
Entry Page: http://bobfiddaman.blogspot.com/2010/10/seroxat-truth-suit-comprises-only-314.html
Exit Page: http://bobfiddaman.blogspot.com/2010/10/seroxat-truth-suit-comprises-only-314.html
Referrer: No referrer
Exposing the BBC connection in the Seroxat User Group FRAUD - Noreen Bray Chair of Good Relations Wales
Exposing the BBC connection in the Seroxat User Group FRAUD - Noreen Bray Chair of Good Relations Wales
Good Relations Wales
People
Noreen Bray, Chair: "Born in Cardiff, Noreen Bray joined the BBC as a graduate trainee. For thirteen years she broadcast widely on TV and radio, including regular contributions to BBC Woman’s Hour. Prior to joining Good Relations she was co-presenter of BBC Wales’ nightly news programme ‘Wales Today’ and reporter on the current affairs series ‘Week In Week Out’."
http://209.85.229.132/search?q=cache:DJuwRMbhrL8J:www.goodrelationswales.co.uk/people.html+noreen+bray&cd=1&hl=en&ct=clnk
Good Relations Wales
People
Noreen Bray, Chair: "Born in Cardiff, Noreen Bray joined the BBC as a graduate trainee. For thirteen years she broadcast widely on TV and radio, including regular contributions to BBC Woman’s Hour. Prior to joining Good Relations she was co-presenter of BBC Wales’ nightly news programme ‘Wales Today’ and reporter on the current affairs series ‘Week In Week Out’."
http://209.85.229.132/search?q=cache:DJuwRMbhrL8J:www.goodrelationswales.co.uk/people.html+noreen+bray&cd=1&hl=en&ct=clnk
Tuesday, 12 October 2010
Seroxat TRUTH - Fiddaman was on cocktail Tramadol, Dothiepan & Seroxat
Fiddaman said -
OK, I use a CPAP Machine to 'aid' me when I'm sleeping. I average about 4 hours sleep per night!!!!!
"I take 40mg of Paroxetine (Seroxat) per day for depression.50mg Tramadol per day for my arthritis.75mg Dothiepan just before bedtime (another anti depressant though my GPsays it should help me get a better sleep)15mg Zoton (Reflux Osophugus)"
source
http://groups.google.co.uk/group/uk.people.disability/browse_thread/thread/b0ba9fc3e9295d81?hl=en-GB&q=fiddaman+benefit
see also -
http://health.groups.yahoo.com/group/criticalpsychiatry/message/63577
OK, I use a CPAP Machine to 'aid' me when I'm sleeping. I average about 4 hours sleep per night!!!!!
"I take 40mg of Paroxetine (Seroxat) per day for depression.50mg Tramadol per day for my arthritis.75mg Dothiepan just before bedtime (another anti depressant though my GPsays it should help me get a better sleep)15mg Zoton (Reflux Osophugus)"
source
http://groups.google.co.uk/group/uk.people.disability/browse_thread/thread/b0ba9fc3e9295d81?hl=en-GB&q=fiddaman+benefit
see also -
http://health.groups.yahoo.com/group/criticalpsychiatry/message/63577
Seroxat LIAR Fiddaman claims all his withdrawal problems were down to Seroxat
http://chipmunkapublishing.co.uk/shop/index.php?main_page=product_info&products_id=1558
ISBN: 978-1-84991-120-7
Published: 2010
Pages: 331
Key Themes: depression, pharmacy, campaign, seroxat
ISBN: 978-1-84991-120-7
Published: 2010
Pages: 331
Key Themes: depression, pharmacy, campaign, seroxat
Seroxat TRUTH - for over last 6 years John Simmons was taking Lustral not Seroxat
John, 56, a lorry driver, took Seroxat for 10 years and has been on another anti-depressant, Lustral for the past six years.
http://www.huntspost.co.uk/content/hunts/news/story.aspx?brand=HPTOnline&category=News&tBrand=cambs24&tCategory=NewsHPT&itemid=WEED07%20Feb%202007%2011%3A20%3A56%3A610
http://www.huntspost.co.uk/content/hunts/news/story.aspx?brand=HPTOnline&category=News&tBrand=cambs24&tCategory=NewsHPT&itemid=WEED07%20Feb%202007%2011%3A20%3A56%3A610
Seroxat LIAR Janice Simmons claimed husband John unable to get off Seroxat
She said her husband John had been on Seroxat since 1991, had made a suicide attempt when initially prescribed the drug and was unable to get off it after 5 attempts.
http://www.seroxatusergroup.org.uk/EMEA%20minutes%20April%202004.pdf
http://www.seroxatusergroup.org.uk/EMEA%20minutes%20April%202004.pdf
Seroxat TRUTH - suit comprises only 314 clients © 2009 FierceMarkets
Seroxat suit comprises only 314 clients © 2009 FierceMarkets
http://209.85.229.132/search?q=cache:HVY-Qp_p-YAJ:www.fiercepharma.com/story/uk-patients-sue-paxil-withdrawal/2008-01-09+harvey+seroxat&cd=14&hl=en&ct=clnk
Poor Paxil. It was the first antidepressant to be slapped with a suicide-risk warning. It's drawn fire--and lawsuits--from U.S. patients who say they went into withdrawal when trying to quit treatment. Now, a group of UK patients are suing GlaxoSmithKline for the same withdrawal problems, seeking up to $98,000 per patient, or $31 million-plus with the 314 patients participating so far. Of course, it's not simply the monetary damages that could hurt, but the attendant publicity, which might turn off potential patients.
Sold as Seroxat in the UK, the drug is "defective" under Britain's 1987 Consumer Protection Act--or so says the patients' attorney, Mark Harvey of the law firm Hugh James. A few of his clients have not been able to stop taking Seroxat because of their withdrawal symptoms, he says. When they began treatment, not only was there no warning of withdrawal problems on the drug's label, but it specifically stated that the drug was not addictive.
Harvey has been working on this suit since at least 2004, when it first became fashionable to sue Glaxo for Paxil/Seroxat-related woes. The drug was banned in the UK for kids under 18 in 2003; since then, lawsuits over paroxetine's side effects have flown on both sides of the Atlantic.Read more: http://209.85.229.132/search?q=cache:HVY-Qp_p-YAJ:www.fiercepharma.com/story/uk-patients-sue-paxil-withdrawal/2008-01-09+harvey+seroxat&cd=14&hl=en&ct=clnk
http://209.85.229.132/search?q=cache:HVY-Qp_p-YAJ:www.fiercepharma.com/story/uk-patients-sue-paxil-withdrawal/2008-01-09+harvey+seroxat&cd=14&hl=en&ct=clnk
Poor Paxil. It was the first antidepressant to be slapped with a suicide-risk warning. It's drawn fire--and lawsuits--from U.S. patients who say they went into withdrawal when trying to quit treatment. Now, a group of UK patients are suing GlaxoSmithKline for the same withdrawal problems, seeking up to $98,000 per patient, or $31 million-plus with the 314 patients participating so far. Of course, it's not simply the monetary damages that could hurt, but the attendant publicity, which might turn off potential patients.
Sold as Seroxat in the UK, the drug is "defective" under Britain's 1987 Consumer Protection Act--or so says the patients' attorney, Mark Harvey of the law firm Hugh James. A few of his clients have not been able to stop taking Seroxat because of their withdrawal symptoms, he says. When they began treatment, not only was there no warning of withdrawal problems on the drug's label, but it specifically stated that the drug was not addictive.
Harvey has been working on this suit since at least 2004, when it first became fashionable to sue Glaxo for Paxil/Seroxat-related woes. The drug was banned in the UK for kids under 18 in 2003; since then, lawsuits over paroxetine's side effects have flown on both sides of the Atlantic.Read more: http://209.85.229.132/search?q=cache:HVY-Qp_p-YAJ:www.fiercepharma.com/story/uk-patients-sue-paxil-withdrawal/2008-01-09+harvey+seroxat&cd=14&hl=en&ct=clnk
Seroxat LIAR Janice claimed the group represented 10,000 people
http://www.seroxatusergroup.org.uk/EMEA%20minutes%20April%202004.pdf
extract
Janice said the group represents over 10,000 people all of whom have suffered adverse effects/withdrawal symptoms of Seroxat. She said her husband John had been on Seroxat since 1991, had made a suicide attempt when initially prescribed the drug and was unable to get off it after 5 attempts. His 1st wife had committed suicide on the 3rd attempt, within 3 weeks of being prescribed Prozac. Janice stated that considering the size of the group present today they had first hand knowledge of 3 suicide attempts - what did that tell them? Janice also stated that she had been offered the drugs 4 times since her mothers death 2 years ago because she was feeling very sad, but she said she refused the drugs as it was part of life and the pain would ease in time.
extract
Janice said the group represents over 10,000 people all of whom have suffered adverse effects/withdrawal symptoms of Seroxat. She said her husband John had been on Seroxat since 1991, had made a suicide attempt when initially prescribed the drug and was unable to get off it after 5 attempts. His 1st wife had committed suicide on the 3rd attempt, within 3 weeks of being prescribed Prozac. Janice stated that considering the size of the group present today they had first hand knowledge of 3 suicide attempts - what did that tell them? Janice also stated that she had been offered the drugs 4 times since her mothers death 2 years ago because she was feeling very sad, but she said she refused the drugs as it was part of life and the pain would ease in time.
Subscribe to:
Posts (Atom)







